Deutsche Bank analyst Pito Chickering lowered the firm’s price target on Zimmer Biomet (ZBH) to $107 from $115 and keeps a Hold rating on the shares following the “choppy” Q4 print.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZBH:
- Zimmer Biomet price target lowered to $125 from $130 at RBC Capital
- Zimmer Biomet price target lowered to $119 from $126 at Raymond James
- Zimmer Biomet price target lowered to $130 from $138 at Baird
- Zimmer Biomet Reports Strong 2024 Financial Performance
- ZBH Upcoming Earnings Report: What to Expect?